Press Releases

Elligo Launches Expanded System of Accelerated Research (SOAR™)

Elligo Health Research®, a healthcare-enabling research organization, is launching their fully realized System of Accelerated Research (SOAR) model for decentralized (DCTs) and hybrid trial models with fully remote monitoring capabilities.

Elucid Digital Health’s dashboard gives pharma and CROs real time patient adherence data during a clinical trial

Elucid’s Pill Connect dispensing system provides CROs and pharma the ability to show adherence across the whole trial, by country, by site even down to the individual patient number in real time.

Profacgen Updated Its CLIP-Seq Service for RNA-Protein Interaction Study

Creative Biostructure Released Cryo-EM for Gene Therapy

Creative BioMart Updated Its Bacterial Expression Systems for Protein Expression Service

Creative Bioarray Release Validated Preclinical Models to Support All Stages of Drug Discovery

Research Presentation Strategies Announces New System Enabling the First-Ever Full Day Virtual FDA Drug Approval AdComm Presentation

Research Presentation Strategies (RPS), the leader in FDA advisory committee (AdComm) presentation support, announced the use of their technology platform for a successful virtual Cardio-Renal Drug Advisory Committee (CRDAC) meeting that took place on July 15, 2020. The RPS platform was utilized by a sponsor last week for the first fully virtual, day-long drug approval AdComm presentation.

Matexcel Enlarged Its Chitosan Products Offerings

Lifeasible Supports a Comprehensive Range of Environmental Tests

Creative Diagnostics Expands Response to COVID-19 to Recombinant SARS-CoV-2 RBD Mutants

The global cases of COVID-19 are expected to soar unceasingly, and to facilitate related research worldwide, Creative Diagnostics integrates recombinant SARS-CoV-2 RBD mutants to its SARS-CoV-2 products and services.

CsPbX3 Perovskite Nanocrystals Are Now Available at Creative Diagnostics

Quantum dots have long been a focus of researches on photovoltaic devices, biosensors and catalysis and as a global supplier with experienced technical teams, Creative Diagnostics introduces CsPbX3 Perovskite Nanocrystals for various applications.

CD Bioparticles: A Trustworthy Provider of All Sorts of PEG Conjugations

As a top-class institution as well as experienced supplier in drug delivery, CD Bioparticles now launches cover-all PEG conjugations to global clients.

Latest Updates: CAR Design and Construction Services Are Optimized at Creative Biolabs

Based on the leading CellRapeuticsTM CAR technology platform, Creative Biolabs has optimized the CAR design and construction services, especially for CAR-T therapy and CAR-NK therapy.

ERT Expands eCOA Solution for Higher Fidelity CNS Assessments

Partnership with Cogstate delivers digital cognitive assessments to improve the speed and effectiveness of clinical trials

TrialScope Welcomes Moderna into Its Community of Clinical Trial Sponsors

TrialScope, the global leader in clinical trial disclosure and transparency management technology, adds Moderna to its growing customer roster.

Alfa Chemistry Optimized Precious Metal Catalysts Recovery and Refining Service

Alfa Chemistry announced earlier this month that it has taken measures to optimize metal catalysts recovery and refining service.

Noxopharm Reports Idronoxil Achieves Major Industry Goal of Converting ‘Cold’ Tumors to ‘Hot’

Noxopharm, a clinical-stage Australian oncology drug development company listed on the ASX (ASX:NOX), has claimed a breakthrough in the search for restoring immune function within “cold” microtumors, converting them to so-called “hot” tumors.

Life Sciences Industry Accelerates Growth and Navigates COVID-19 with eClinical Solutions’ ASCEND Clinical Data Services

Boston pharma tech innovator supports faster clinical trials and regulatory drug approvals with advanced technology platforms and statistical expertise

ERT Leader Recognized by PharmaVoice for Delivering Innovation in Clinical Trial Imaging

Enhanced solution improves data accuracy to increase respiratory clinical trial efficiencies

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd

Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd (SB3000 Ltd), a pioneer in green, continuous manufacturing of pharmaceutical products.